125 related articles for article (PubMed ID: 28091434)
1. Serum obestatin and omentin levels in patients with diabetic nephropathy.
Zorlu M; Kiskac M; Güler EM; Gültepe I; Yavuz E; Çelik K; Kocyigit A
Niger J Clin Pract; 2017 Feb; 20(2):182-187. PubMed ID: 28091434
[TBL] [Abstract][Full Text] [Related]
2. Role of omentin 1 and IL-6 in type 2 diabetes mellitus patients with diabetic nephropathy.
Senthilkumar GP; Anithalekshmi MS; Yasir M; Parameswaran S; Packirisamy RM; Bobby Z
Diabetes Metab Syndr; 2018; 12(1):23-26. PubMed ID: 28864059
[TBL] [Abstract][Full Text] [Related]
3. Serum omentin-1 levels in diabetic and nondiabetic patients with chronic kidney disease.
Tekce H; Tekce BK; Aktas G; Alcelik A; Sengul E
Exp Clin Endocrinol Diabetes; 2014 Sep; 122(8):451-6. PubMed ID: 24918534
[TBL] [Abstract][Full Text] [Related]
4. Serum omentin-1 levels as a possible risk factor of mortality in patients with diabetes on haemodialysis.
Kocijancic M; Vujicic B; Racki S; Cubranic Z; Zaputovic L; Dvornik S
Diabetes Res Clin Pract; 2015 Oct; 110(1):44-50. PubMed ID: 26293449
[TBL] [Abstract][Full Text] [Related]
5. Association of serum omentin levels with cardiac autonomic neuropathy in patients with type 2 diabetes mellitus: a hospital-based study.
Jung CH; Jung SH; Kim BY; Kim CH; Kang SK; Mok JO
Cardiovasc Diabetol; 2015 Oct; 14():140. PubMed ID: 26466574
[TBL] [Abstract][Full Text] [Related]
6. Long-term impact of vertical banded gastroplasty (VBG) on plasma concentration of leptin, soluble leptin receptor, ghrelin, omentin-1, obestatin, and retinol binding protein 4 (RBP4) in patients with severe obesity.
Siejka A; Jankiewicz-Wika J; Kołomecki K; Cywiński J; Piestrzeniewicz K; Swiętosławski J; Stępień H; Komorowski J
Cytokine; 2013 Nov; 64(2):490-3. PubMed ID: 24011638
[TBL] [Abstract][Full Text] [Related]
7. Association between plasma omentin-1 levels in type 2 diabetic patients and peripheral artery disease.
Biscetti F; Nardella E; Bonadia N; Angelini F; Pitocco D; Santoliquido A; Filipponi M; Landolfi R; Flex A
Cardiovasc Diabetol; 2019 Jun; 18(1):74. PubMed ID: 31167666
[TBL] [Abstract][Full Text] [Related]
8. Assessment of the Diagnostic Utility of Serum Omentin 1 and IL-6 in Early Stages of Diabetic Nephropathy.
Devi S; Sahu S; Behera KK; Sahoo D; Priyadarshini N
J Assoc Physicians India; 2022 Apr; 70(4):11-12. PubMed ID: 35443364
[TBL] [Abstract][Full Text] [Related]
9. Serum omentin-1, inflammation and carotid atherosclerosis in patients with non-diabetic chronic kidney disease.
Sengul E; Duygulu G; Dindar S; Bunul F
Ren Fail; 2013 Sep; 35(8):1089-93. PubMed ID: 23883412
[TBL] [Abstract][Full Text] [Related]
10. The Effects of Blood Glucose Regulation in Omentin-1 Levels among Diabetic Patients.
Arman Y; Kirna K; Ugurlukisi B; Kutlu O; Dikker O; Cil EO; Akarsu M; Ozcan M; Yuruyen G; Demir P; Altun O; Ozsenel EB; Erdem MG; Sandikci R; Tukek T
Exp Clin Endocrinol Diabetes; 2017 Apr; 125(4):262-266. PubMed ID: 28073124
[No Abstract] [Full Text] [Related]
11. Plasma omentin levels are associated with vascular endothelial function in patients with type 2 diabetes at elevated cardiovascular risk.
Hayashi M; Morioka T; Hatamori M; Kakutani Y; Yamazaki Y; Kurajoh M; Motoyama K; Mori K; Fukumoto S; Shioi A; Shoji T; Emoto M; Inaba M
Diabetes Res Clin Pract; 2019 Feb; 148():160-168. PubMed ID: 30641171
[TBL] [Abstract][Full Text] [Related]
12. Independent and opposite associations of serum levels of omentin-1 and adiponectin with increases of glycaemia and incident type 2 diabetes in an older population: KORA F4/FF4 study.
Herder C; Kannenberg JM; Niersmann C; Huth C; Carstensen-Kirberg M; Wittenbecher C; Schulze M; Blüher M; Rathmann W; Peters A; Roden M; Meisinger C; Thorand B
Eur J Endocrinol; 2017 Oct; 177(4):277-286. PubMed ID: 28679518
[TBL] [Abstract][Full Text] [Related]
13. Low serum omentin levels in the elderly population with Type 2 diabetes and polyneuropathy.
Herder C; Bongaerts BW; Ouwens DM; Rathmann W; Heier M; Carstensen-Kirberg M; Koenig W; Thorand B; Roden M; Meisinger C; Ziegler D;
Diabet Med; 2015 Nov; 32(11):1479-83. PubMed ID: 26094489
[TBL] [Abstract][Full Text] [Related]
14. Plasma omentin levels are inversely associated with atherosclerosis in type 2 diabetes patients with increased plasma adiponectin levels: a cross-sectional study.
Nishimura M; Morioka T; Hayashi M; Kakutani Y; Yamazaki Y; Kurajoh M; Mori K; Fukumoto S; Shioi A; Shoji T; Inaba M; Emoto M
Cardiovasc Diabetol; 2019 Dec; 18(1):167. PubMed ID: 31805941
[TBL] [Abstract][Full Text] [Related]
15. Assessment of Serum Concentrations of Ghrelin, Obestatin, Omentin-1, and Apelin in Children with Type 1 Diabetes.
Polkowska A; Szczepaniak I; Bossowski A
Biomed Res Int; 2016; 2016():8379294. PubMed ID: 26904686
[TBL] [Abstract][Full Text] [Related]
16. Serum and urinary SOD3 in patients with type 2 diabetes: comparison with early chronic kidney disease patients and association with development of diabetic nephropathy.
Kuo CW; Chen HL; Tu MY; Chen CM
Am J Physiol Renal Physiol; 2019 Jan; 316(1):F32-F41. PubMed ID: 30303710
[TBL] [Abstract][Full Text] [Related]
17. Endocan and albuminuria in type 2 diabetes mellitus.
Cikrikcioglu MA; Erturk Z; Kilic E; Celik K; Ekinci I; Yasin Cetin AI; Ozkan T; Cetin G; Dae SA; Kazancioglu R; Erkoc R
Ren Fail; 2016 Nov; 38(10):1647-1653. PubMed ID: 27756187
[TBL] [Abstract][Full Text] [Related]
18. Association of Circulating Omentin-1 with Osteoporosis in a Chinese Type 2 Diabetic Population.
Yan P; Xu Y; Zhang Z; Zhu J; Miao Y; Gao C; Wan Q
Mediators Inflamm; 2020; 2020():9389720. PubMed ID: 33149724
[TBL] [Abstract][Full Text] [Related]
19. Changes in Serum Nampt Levels and Its Significances in Diabetic Nephropathy Patients-The Potential Role of Nampt in T2DM with Diabetic Nephropathy.
Ma X; An L; Wang Q
Endocr Metab Immune Disord Drug Targets; 2017; 17(2):114-124. PubMed ID: 28699485
[TBL] [Abstract][Full Text] [Related]
20. Adiponectin may mediate the association between omentin, circulating lipids and insulin sensitivity: results from the KORA F4 study.
Herder C; Ouwens DM; Carstensen M; Kowall B; Huth C; Meisinger C; Rathmann W; Roden M; Thorand B
Eur J Endocrinol; 2015 Apr; 172(4):423-32. PubMed ID: 25733068
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
